컴퍼스 패스웨이스(ADR) (CMPS) 주가

컴퍼스 패스웨이스(ADR)(CMPS)는 NAS에 상장된 Healthcare · Medical Care Facilities 기업입니다. 현재가 $15.19 (+1.27%), 시가총액 $1.40B.

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

핵심 지표

• 현재가: $15.19 (+1.27%)
• 시가총액: $1.40B
• 섹터: Healthcare
• 산업: Medical Care Facilities
• 거래소: NAS

컴퍼스 패스웨이스(ADR)의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

컴퍼스 패스웨이스(ADR) 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 적극 매수 (4.6 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 16.11
• 순이익률: 0.00%
• 영업이익률: 0.00%

자주 묻는 질문